28 related articles for article (PubMed ID: 15223957)
1. pH Responsive 5-Fluorouracil Loaded Biocompatible Nanogels For Topical Chemotherapy of Aggressive Melanoma.
Sahu P; Kashaw SK; Sau S; Kushwah V; Jain S; Agrawal RK; Iyer AK
Colloids Surf B Biointerfaces; 2019 Feb; 174():232-245. PubMed ID: 30465998
[TBL] [Abstract][Full Text] [Related]
2. Expression of novel cancer/testis antigen TMEM31 increases during metastatic melanoma progression.
Li J; Zou X; Li C; Zhong J; Chen Y; Zhang X; Qi F; Li M; Cai Z; Tang A
Oncol Lett; 2017 Apr; 13(4):2269-2273. PubMed ID: 28454390
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic biomarkers in melanoma.
Weinstein D; Leininger J; Hamby C; Safai B
J Clin Aesthet Dermatol; 2014 Jun; 7(6):13-24. PubMed ID: 25013535
[TBL] [Abstract][Full Text] [Related]
4. The histological diagnosis of metastases to the breast from extramammary malignancies.
Lee AH
J Clin Pathol; 2007 Dec; 60(12):1333-41. PubMed ID: 18042689
[TBL] [Abstract][Full Text] [Related]
5. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
6. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
7. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
10. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
Gajjar NA; Cochran AJ; Binder SW
Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
[TBL] [Abstract][Full Text] [Related]
11. [Expression of cancer testis (CT) antigens in pediatric and adolescent melanomas].
Behrendt N; Schultewolter T; Busam K; Frosina D; Spagnoli G; Jungbluth A
Pathologe; 2017 Jul; 38(4):303-311. PubMed ID: 28631119
[TBL] [Abstract][Full Text] [Related]
12. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.
Ordóñez NG
Hum Pathol; 2014 Feb; 45(2):191-205. PubMed ID: 23648379
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
